Drug Shortage Report for PAT-GALANTAMINE ER
| Report ID | 202024 |
| Drug Identification Number | 02316943 |
| Brand name | PAT-GALANTAMINE ER |
| Common or Proper name | PAT*-galantamine ER 8mg |
| Company Name | JANSSEN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALANTAMINE |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 30 |
| ATC code | N06DA |
| ATC description | ANTI-DEMENTIA DRUGS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-08-15 |
| Actual start date | 2023-08-15 |
| Estimated end date | 2023-10-13 |
| Actual end date | 2023-10-04 |
| Shortage status | Resolved |
| Updated date | 2023-10-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-10-05 | French | Compare |
| v3 | 2023-10-05 | English | Compare |
| v2 | 2023-08-16 | French | Compare |
| v1 | 2023-08-16 | English | Compare |
Showing 1 to 4 of 4